Literature DB >> 28155592

Impact of cardiopulmonary bypass surgery on cytokines in epicardial adipose tissue: comparison with subcutaneous fat.

Lukas Mach1,2, Helena Bedanova3, Miroslav Soucek2, Michal Karpisek4, Tomas Konecny5, Petr Nemec2,3, Marek Orban3,4.   

Abstract

BACKGROUND: Cardiac surgery and cardiopulmonary bypass (CPB) have been shown to stimulate a systemic inflammatory response which has been associated with adverse postoperative outcomes. Adipose tissue, both epicardial (EAT) and subcutaneous (SAT), is a known source of inflammatory cytokines, but its role in the pathophysiology of surgery- and CPB-induced systemic inflammatory response has not been fully elucidated. Therefore, we conducted a study to establish levels of selected cytokines in EAT and SAT prior to and after surgery with CPB.
METHODS: Adipose tissue samples were obtained from patients undergoing planned cardiac surgery on CPB. Samples from EAT and SAT were collected before and immediately after CPB. Levels of tumour necrosis factor-α (TNF-α), interleukin-6 (IL-6), adipocyte fatty acid-binding protein (AFABP), leptin and adiponectin were determined by ELISA, which were adjusted for a total concentration of proteins in the individual samples.
RESULTS: Samples from 77 patients (mean age 67.68 ± 11.5 years) were obtained and analysed. Leptin, adiponectin, TNF-α and AFABP were shown to decrease their concentrations statistically significantly in the EAT after CPB while no statistically significant drop was observed in the SAT. On the contrary, IL-6 showed only a slight and statistically insignificant decrease in the EAT after CPB and it was in the SAT where a statistically significant drop was observed. DISCUSSION: One of the most relevant findings of this study was the marked decrease in EAT levels of TNF-α, AFABP, leptin and adiponectin after the CPB termination. Our results suggest that EAT might serve as a pool of cytokines which are released into the circulation in reaction to surgery with CPB. Should these novel findings be confirmed, new strategies to assess and possibly reduce EAT contribution on adverse outcomes of cardiac surgery may be developed.

Entities:  

Keywords:  cardiopulmonary bypass; cytokines; epicardial adipose tissue; inflammation; subcutaneous adipose tissue; systemic inflammatory response

Mesh:

Substances:

Year:  2016        PMID: 28155592     DOI: 10.1177/0267659116683791

Source DB:  PubMed          Journal:  Perfusion        ISSN: 0267-6591            Impact factor:   1.972


  6 in total

1.  Postoperative Dynamic of Leptin and Fibroblast Growth Factor 21 in 123 Patients Recovering from Cardiac Surgery.

Authors:  Da Liu; Danyal Ghani; Wilson Y Szeto; Krzysztof Laudanski
Journal:  Med Sci Monit       Date:  2022-09-29

2.  Association between epicardial adipose tissue and adverse outcomes in coronary heart disease patients with percutaneous coronary intervention.

Authors:  Changqing Lu; Helei Jia; Zhentao Wang
Journal:  Biosci Rep       Date:  2019-05-07       Impact factor: 3.840

Review 3.  Characterization of the inflammatory-metabolic phenotype of heart failure with a preserved ejection fraction: a hypothesis to explain influence of sex on the evolution and potential treatment of the disease.

Authors:  Milton Packer; Carolyn S P Lam; Lars H Lund; Mathew S Maurer; Barry A Borlaug
Journal:  Eur J Heart Fail       Date:  2020-06-26       Impact factor: 15.534

Review 4.  Inflammation and Cardiovascular Diseases in the Elderly: The Role of Epicardial Adipose Tissue.

Authors:  Maddalena Conte; Laura Petraglia; Paolo Poggio; Vincenza Valerio; Serena Cabaro; Pasquale Campana; Giuseppe Comentale; Emilio Attena; Vincenzo Russo; Emanuele Pilato; Pietro Formisano; Dario Leosco; Valentina Parisi
Journal:  Front Med (Lausanne)       Date:  2022-02-15

Review 5.  The role of ectopic adipose tissue: benefit or deleterious overflow?

Authors:  Toon J I De Munck; Peter B Soeters; Ger H Koek
Journal:  Eur J Clin Nutr       Date:  2020-08-14       Impact factor: 4.016

Review 6.  NAFLD and cardiovascular diseases: a clinical review.

Authors:  Philipp Kasper; Anna Martin; Sonja Lang; Fabian Kütting; Tobias Goeser; Münevver Demir; Hans-Michael Steffen
Journal:  Clin Res Cardiol       Date:  2020-07-21       Impact factor: 5.460

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.